Privacy PolicyTerms of Service
OslerMarket
K
Ask OslerLibraryLearn
OslerMarket

Filtered resources

Clinical library

444 resources

Explore a topic. Choose a collection. Find your next resource.

444 resources
Clear filters

Collections 3

Cardiology: ACS & Heart Failure16 resourcesHypertension9 resourcesECG & More17 resources

Collections

3 of 45
  • Cardiology: ACS & Heart Failure16 resourcesACS by Labu Albert · MANAGEMENT OF ACUTE CORONARY SYNDROME …
  • Hypertension9 resources2025 AHA/ACC Guideline for the Management of High Blood Pressure in Adults · ESC 2024 Hypertension Guidelines …
  • ECG & More17 resourcesAN INTRODUCTION TO THE ECG and arrythmias revision ECG Oct 2025 (2) · LITTLE BLACK BOOK OF ECG SECRETS …

Resources

24 shown
Management of hypertensive crisis: British and Irish Hypertension Society Position document coverGuidelines & protocolsManagement of hypertensive crisis: British and Irish Hypertension Society Position documentBritish and Irish Hypertension Society·Cardiology· 2022· 17 pagesThis position paper provides a framework for diagnosing, evaluating, and managing patients with hypertensive crisis, based on critical appraisal of available evidence and expert opinion.
CARDIOVASCULAR DISEASE IN WOMEN: DO WE NEED NEW DIAGNOSTIC AND THERAPEUTIC STRATEGIES? coverClinical reviewsCARDIOVASCULAR DISEASE IN WOMEN: DO WE NEED NEW DIAGNOSTIC AND THERAPEUTIC STRATEGIES?Clinico San Carlos University Hospital, Hospital de la Santa Creu i Sant Pau, Universitary Hospital Fundación Alcorcón, La Paz University Hospital, Universidad Europea de Madrid, Universitary Hospital Santiago de Compostela, University Hospital Vall·Cardiology· 12 pagesThis review discusses the underrecognition and undertreatment of cardiovascular disease in women compared to men, highlighting the need for new diagnostic and therapeutic strategies.
NEWLY DIAGNOSED HEART FAILURE WITH REDUCED EJECTION FRACTION: TIMING, SEQUENCING, AND TITRATION OF GUIDELINE-RECOMMENDED MEDICAL THERAPY coverClinical reviewsNEWLY DIAGNOSED HEART FAILURE WITH REDUCED EJECTION FRACTION: TIMING, SEQUENCING, AND TITRATION OF GUIDELINE-RECOMMENDED MEDICAL THERAPYErasmus MC, Maastricht University Medical Centre, Ikazia Ziekenhuis, Meander Medical Centre, Noordwest Hospital Group, Haaglanden Medical Centre, Amphia Ziekenhuis, Dutch Network for Cardiovascular Research, Zuyderland Medisch Centrum, Medisch Spectrum·Cardiology· 2025· 12 pagesThis document discusses the timing, sequencing, and titration of guideline-recommended medical therapy for newly diagnosed heart failure with reduced ejection fraction.
CHRONIC KIDNEY DISEASE AND CORONARY ARTERY DISEASE coverClinical reviewsCHRONIC KIDNEY DISEASE AND CORONARY ARTERY DISEASEAmerican College of Cardiology·Cardiology· 2019· 16 pagesChronic kidney disease (CKD) is a major risk factor for coronary artery disease (CAD), complicating its management due to the presence of traditional and nontraditional cardiovascular risk factors.
GREAT DEBATE: CLOPIDOGREL SHOULD NOW REPLACE ASPIRIN FOR LONG-TERM SECONDARY PREVENTION OF CORONARY ARTERY DISEASE coverClinical reviewsGREAT DEBATE: CLOPIDOGREL SHOULD NOW REPLACE ASPIRIN FOR LONG-TERM SECONDARY PREVENTION OF CORONARY ARTERY DISEASEUniversity of Glasgow, Cardiocentro Ticino Institute, University of Bern, Catholic University School of Medicine, University of Campania 'Luigi Vanvitelli', Imperial College London, East and North Hertfordshire NHS Trust, Royal Brompton Hospital·Cardiology· 14 pagesThis document discusses the debate surrounding the use of clopidogrel versus aspirin for long-term secondary prevention of coronary artery disease (CAD). It presents evidence suggesting that clopidogrel may offer superior ischemic protection without the bleeding risk associated with aspirin.
SINGLE ANTIPLATELET THERAPY DIRECTLY AFTER PERCUTANEOUS CORONARY INTERVENTION IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS: THE OPTICA STUDY coverClinical reviewsSINGLE ANTIPLATELET THERAPY DIRECTLY AFTER PERCUTANEOUS CORONARY INTERVENTION IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS: THE OPTICA STUDYDepartment of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands; Department of Cardiology, Amsterdam UMC, Vrije University (VU), Amsterdam Cardiovascular Sciences, Amsterdam, the Netherlands·Cardiology· 2023· 13 pagesThis study evaluates the feasibility and safety of ticagrelor or prasugrel monotherapy directly following percutaneous coronary intervention (PCI) in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS).
LIPID MANAGEMENT FOR THE PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE coverClinical reviewsLIPID MANAGEMENT FOR THE PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASEErin D. Michos, M.D., M.H.S., John W. McEvoy, M.B., B.Ch., Roger S. Blumenthal, M.D.·Cardiology· 2019· 11 pagesThis review summarizes current methods of managing serum lipid levels to prevent atherosclerotic cardiovascular disease, highlighting the importance of cholesterol management and recent guidelines.
MAGNESIUM AND BLOOD PRESSURE REGULATION: SYSTEMIC AND RENAL MECHANISMS coverClinical reviewsMAGNESIUM AND BLOOD PRESSURE REGULATION: SYSTEMIC AND RENAL MECHANISMSnull·Cardiology· 2026· 10 pagesThis document explores the relationship between magnesium deficiency and elevated blood pressure, detailing the systemic and renal mechanisms involved. It discusses the effects of magnesium supplementation on blood pressure regulation and the underlying physiological processes.
BRAIN MINERALOCORTICOID RECEPTOR ACTIVATION AND ANTAGONISM IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A HYPOTHESIS coverClinical reviewsBRAIN MINERALOCORTICOID RECEPTOR ACTIVATION AND ANTAGONISM IN HEART FAILURE WITH PRESERVED EJECTION FRACTION: A HYPOTHESISKarolinska Institutet, Karolinska University Hospital, University of Michigan·Cardiology· 2026· 3 pagesThis document discusses the role of brain mineralocorticoid receptors in heart failure with preserved ejection fraction, proposing a hypothesis regarding their activation and antagonism.
PREVENTION OF HEART FAILURE coverGuidelines & protocolsPREVENTION OF HEART FAILUREHeart Failure Association, European Association of Preventive Cardiology, Association of Cardiovascular Nursing & Allied Professions·Cardiology· 21 pagesThis document is a scientific statement from the Heart Failure Association, the European Association of Preventive Cardiology, and the Association of Cardiovascular Nursing & Allied Professions, focusing on strategies for preventing heart failure.
HEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION: A HEART FAILURE SOCIETY OF AMERICA SCIENTIFIC STATEMENT coverClinical reviewsHEART FAILURE WITH MILDLY REDUCED EJECTION FRACTION: A HEART FAILURE SOCIETY OF AMERICA SCIENTIFIC STATEMENTHeart Failure Society of America·Cardiology· 2026· 16 pagesThis scientific statement provides a comprehensive review of heart failure with mildly reduced ejection fraction (HFmrEF), focusing on its epidemiology, clinical characteristics, and pathophysiology, while offering a clinical framework for treatment.
THE FENOFIBRATE ERA coverClinical reviewsTHE FENOFIBRATE ERAnull·Cardiology· 2025· 12 pagesThis review critically assesses the role of fibrates in modern medicine, particularly in the context of atherosclerotic cardiovascular disease and residual cardiovascular risk in patients with mixed dyslipidaemia.
HIGH-SENSITIVITY TROPONINS AND MORTALITY IN THE GENERAL POPULATION coverClinical reviewsHIGH-SENSITIVITY TROPONINS AND MORTALITY IN THE GENERAL POPULATIONUniversity of Galway School of Medicine, Johns Hopkins Hospital, Johns Hopkins University School of Medicine, University of Maryland School of Medicine·Cardiology· 2023· 11 pagesThis study aimed to characterize correlations between high-sensitivity troponin assays and their associations with mortality in adults without cardiovascular disease.
GREAT DEBATE: IN PATIENTS WITH DECOMPENSATED HEART FAILURE, ACETAZOLAMIDE IN ADDITION TO LOOP DIURETICS IS THE FIRST CHOICE coverClinical reviewsGREAT DEBATE: IN PATIENTS WITH DECOMPENSATED HEART FAILURE, ACETAZOLAMIDE IN ADDITION TO LOOP DIURETICS IS THE FIRST CHOICEZiekenhuis Oost-Limburg, Hasselt University, University Hospital Jena, Hannover Medical School·Cardiology· 11 pagesThis document presents a debate on the use of acetazolamide in addition to loop diuretics for patients with decompensated heart failure, discussing both the advantages and disadvantages of this treatment approach.
PERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFTING IN NON-ST-ELEVATION CORONARY SYNDROMES AND MULTIVESSEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS coverClinical reviewsPERCUTANEOUS CORONARY INTERVENTION VERSUS CORONARY ARTERY BYPASS GRAFTING IN NON-ST-ELEVATION CORONARY SYNDROMES AND MULTIVESSEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSISHala Kakar, MD, Frederik T.W. Groenland, MD, Jacob J. Elscot, BSc, Riccardo Rinaldi, MD, Alessandra Scoccia, MD, Isabella Kardys, MD, PhD, Rutger Jan Nuis, MD, PhD, Jeroen Wilschut, MD, Wijnand K. Den Dekker, MD, PhD, Joost Daemen, MD, PhD, Felix·Cardiology· 7 pagesThis systematic review and meta-analysis compares the clinical impact of percutaneous coronary intervention (PCI) with that of coronary artery bypass graft surgery (CABG) in patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) and multivessel disease (MVD).
PROMOTION OF HEALTHY NUTRITION IN PRIMARY AND SECONDARY CARDIOVASCULAR DISEASE PREVENTION: A CLINICAL CONSENSUS STATEMENT FROM THE EUROPEAN ASSOCIATION OF PREVENTIVE CARDIOLOGY coverClinical reviewsPROMOTION OF HEALTHY NUTRITION IN PRIMARY AND SECONDARY CARDIOVASCULAR DISEASE PREVENTION: A CLINICAL CONSENSUS STATEMENT FROM THE EUROPEAN ASSOCIATION OF PREVENTIVE CARDIOLOGYEuropean Association of Preventive Cardiology·Cardiology· 2023· 11 pagesThis position paper discusses the importance of healthy nutrition in the prevention of primary and secondary cardiovascular diseases, providing a consensus statement from experts in the field.
APPRAISING THE PRECLINICAL EVIDENCE OF THE ROLE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN ANTENATAL PROGRAMMING OF MATERNAL AND OFFSPRING CARDIOVASCULAR HEALTH ACROSS THE LIFE COURSE: MOVING THE FIELD FORWARD: A SCIENTIFIC STATEMENT FROM THE coverClinical reviewsAPPRAISING THE PRECLINICAL EVIDENCE OF THE ROLE OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN ANTENATAL PROGRAMMING OF MATERNAL AND OFFSPRING CARDIOVASCULAR HEALTH ACROSS THE LIFE COURSE: MOVING THE FIELD FORWARD: A SCIENTIFIC STATEMENT FROM THEAmerican Heart Association·Cardiology· 15 pagesThis document discusses the long-term cardiovascular health implications for women with complicated pregnancies and their offspring, focusing on the role of the renin-angiotensin-aldosterone system in antenatal programming.
PERICARDIOCENTESIS: ULTRASOUND GUIDANCE IS ESSENTIAL coverCase scenariosPERICARDIOCENTESIS: ULTRASOUND GUIDANCE IS ESSENTIALPablo Blanco, Liliana Figueroa, María Fernanda Menéndez, Belén Berrueta·Cardiology· 6 pagesThis case report discusses the importance of ultrasound guidance in performing pericardiocentesis, highlighting a case where a blind technique failed and ultrasound guidance proved effective.
ATRIAL FIBRILLATION coverClinical reviewsATRIAL FIBRILLATIONUniversity of Liverpool, Liverpool Centre for Cardiovascular Sciences, Aalborg University, Centre for Cardiovascular Innovation, Montreal Heart Institute, Hospital Clínic, Universitat de Barcelona, University of Modena and Reggio Emilia, Maastricht·Cardiology· 2026· 14 pagesThis document provides a comprehensive overview of atrial fibrillation, including its management strategies, risk factors, and the impact of lifestyle changes on patient outcomes.
β‑BLOCKER AND CLINICAL OUTCOMES IN PATIENTS AFTER MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW AND META‑ANALYSIS coverClinical reviewsβ‑BLOCKER AND CLINICAL OUTCOMES IN PATIENTS AFTER MYOCARDIAL INFARCTION: A SYSTEMATIC REVIEW AND META‑ANALYSISWenxing Yang, Xuehong Sun, Yushu Zhang, Zhi Lu, Zhilong Shu, Kui Zhang·Cardiology· 2025· 11 pagesThis systematic review and meta-analysis evaluates the long-term therapeutic impact of beta-blocker therapy on clinical outcomes in patients after myocardial infarction (AMI). The study analyzes data from 34 observational studies to assess the effects of beta-blockers on all-cause mortality, cardiac death, and major adverse cardiac events.
DOES THIS PATIENT HAVE VOLUME OVERLOAD? coverClinical reviewsDOES THIS PATIENT HAVE VOLUME OVERLOAD?Benjamin Drum, MD, PhD; Bryce La Course, MD; Mark Kelly, MD; Audrey York, MD; Emily Worrall, MD; Jennifer Martins, MD; Stacy Johnson, MD; Edmund A. Liles Jr, MD·Cardiology· 2026· 10 pagesThis document evaluates the accuracy of clinical examination, radiographic, and laboratory findings for assessing volume overload in nonintubated patients.
TRIPLE VERSUS DUAL LIPID-LOWERING THERAPY IN ACUTE CORONARY SYNDROME: THE ES-BEMPEDACS RANDOMIZED CLINICAL TRIAL coverClinical reviewsTRIPLE VERSUS DUAL LIPID-LOWERING THERAPY IN ACUTE CORONARY SYNDROME: THE ES-BEMPEDACS RANDOMIZED CLINICAL TRIALSergio Raposeiras-Roubín, MD, PhD; Emad Abu Assi, MD, PhD; César Jiménez Méndez, MD; Ester Mínguez de la Guía, MD; José Ángel Pérez Rivera, MD, PhD; Marta Marcos Mangas, MD; Ana Ayesta, MD, PhD; Aitor Uribarri, MD, PhD; Pablo Jorge Pérez, MD; Pablo José·Cardiology· 2023· 10 pagesThis study compares the efficacy of triple versus dual lipid-lowering therapy in patients with acute coronary syndrome (ACS). The findings suggest significant differences in LDL cholesterol levels between the two treatment strategies.
VENTRICULAR AFTERLOAD, PRELOAD, AND CARDIAC FUNCTION coverClinical reviewsVENTRICULAR AFTERLOAD, PRELOAD, AND CARDIAC FUNCTIONSheldon Magder, Douglas Slobod, Marco Leali·Cardiology· 6 pagesThis document presents a paradigm shift in understanding the circulatory system, challenging traditional concepts of preload and afterload in cardiac function. It introduces the concept of ejection 'threshold load' and discusses the implications for cardiac mechanics.
CURRENT AND EMERGING APPROACHES FOR PRIMARY PREVENTION OF CORONARY ARTERY DISEASE USING CARDIAC COMPUTED TOMOGRAPHY coverClinical reviewsCURRENT AND EMERGING APPROACHES FOR PRIMARY PREVENTION OF CORONARY ARTERY DISEASE USING CARDIAC COMPUTED TOMOGRAPHYPolydoros N. Kampaktsis, Carolyn Hennecken, Mrinali Shetty, Laura McLaughlin, Georgios Rampidis, Athanasios Samaras, Dimitrios Avgerinos, Nikolaos Spilias, Toshiki Kuno, Alexandros Briasoulis, Andrew J. Einstein·Cardiology· 2024· 16 pagesThis document reviews the current use of cardiac computed tomography (CT) technologies in the primary prevention of coronary artery disease (CAD), focusing on their effectiveness and emerging applications.
PreviousPage 10 of 19Next

© 2026 Osler Market

Library·Ask Osler·Learn·Terms·Privacy·Support·WhatsApp Channel

For learning purposes. Always consult clinical guidelines.

Ask OslerLibraryLearn
HomeAskLibraryLearnAccount